Read + Share
Elkrief A, Makhnin A, Moses KA, Ahn LS, et al. Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and
Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas. Clin Cancer Res 2023;29:1423-1428.
PMID: 36729110
|
 |
|
Elkrief A, Makhnin A, Moses KA, Ahn LS, et al. Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and
Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas. Clin Cancer Res 2023;29:1423-1428.
PMID: 36729110
|
|
|
|